©2026 Incunabulum LLC. All rights reserved. mg Magazine is a registered trademark of Incunabulum LLC. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with prior written permission.
Tag: rescheduling
Why Cannabis Must Embrace Data-driven Operations
In an increasingly competitive landscape, “good enough” is no longer a sustainable business strategy. As cannabis transitions into a true consumer packaged good, the contrast between patchwork processes and precision systems has never been more consequential. Scaling isn’t just about producing more; it’s about producing consistently. Ed Wells examines the critical role of data-driven tools in cultivation and post-harvest operations. His conclusion? Embracing operational rigor is not a departure from cannabis culture, but the essential evolution needed to protect craftsmanship while ensuring long-term success at scale.
Schedule III: What It Means for Cannabis Dispensaries
While the federal reclassification of cannabis to Schedule III is being hailed as a historic milestone, for dispensary owners, the “victory” comes with a complex set of operational strings attached. From the selective application of 280E tax relief to the slow-moving evolution of the banking sector, the transition is more about precision than celebration. This guide breaks down why the “medical lane” is the new front line of profitability, how to audit your revenue streams for upcoming tax shifts, and why compliance documentation is now more critical than ever.
Schedule III Reality Check: Tax Relief, Regulatory Gaps, and Hype Risk
The Department of Justice moving cannabis from Schedule I to Schedule III is a historic shift, but it isn’t a universal fix. From the multi-million-dollar 280E tax opportunity to the ongoing hurdles for adult-use operators, we break down the real business impact of the 2026 rescheduling order and why federal oversight is about to get a lot more complex.
Rescheduling’s Fine Print: DEA Becomes Mandatory Middleman
The DEA isn’t stepping back; it’s stepping in. While the industry celebrates the end of 280E, the fine print of the new Schedule III order reveals a mandatory federal middleman, undisclosed fees, and a legal “prescription” trap that could leave dispensaries in limbo. Here is what the rescheduling order actually means for your bottom line.
How Cannabis Businesses Should Prepare for a Potential End to 280E
A potential move of cannabis to Schedule III could eventually reshape the industry’s tax burden by ending the reach of Section 280E. But operators should not confuse political momentum with immediate relief. A CPA explains why retroactive tax refunds are unlikely and disciplined compliance still matters. From defensible cost accounting to scenario planning and entity-structure review, the smartest path is cautious preparation rather than reactive change.
M&A: Preparing to Be Lucky
As we await news about rescheduling, we know a new round of mergers, acquisitions, and capital infusions surely will follow. Whether you are a...
Executive Insight with Sunderstorm’s Cameron Clarke
Sunderstorm Inc. Chief Executive Officer Cameron Clarke embodies a rare autodidactic blend of scientific rigor, entrepreneurial spirit, and deep-rooted passion for natural healing. With...
Rescheduling’s Potential Impact on the Vaping Sector
According to Transparency Market Research Inc., the global handheld cannabis vaporizer market will enjoy a robust compound annual growth rate of 13.4 percent between...
Eliminating 280E Could Spark an Investment Frenzy
For the past three to four years, the cannabis industry has experienced an unprecedented and steadily declining access to capital, resulting in slower-than-expected growth...
Lawmakers Attempt to Save Rescheduling, Hemp from Republican Ax
WASHINGTON – Reps. Rashida Tlaib (D-Mich.), Nancy Mace (R-SC), and Morgan McGarvey (D-Ky.) each introduced amendments this week that would block the latest efforts...















